STOCK TITAN

Forte Biosciences: Glazer Capital reports 0% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Forte Biosciences, Inc. (FBRX) is identified in an amended ownership report in which Glazer Capital, LLC and its managing member, Paul J. Glazer, each report beneficial ownership of 0 shares of common stock, or 0% of the class. Glazer Capital says it filed with respect to shares held by funds and managed accounts it manages; the statement says the report is not an admission that either reporting person is a beneficial owner under Section 13 of the Act.

Beneficial ownership (each reporting person) 0 shares Glazer Capital, LLC and Paul J. Glazer; common stock
Percentage of class (each reporting person) 0% Forte Biosciences common stock
beneficial owner regulatory
"beneficial owner of the shares of Common Stock"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
dispositive power regulatory
"Sole Dispositive Power"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many FBRX shares did Glazer Capital report owning?

Glazer Capital, LLC reported beneficial ownership of 0 shares of Forte Biosciences common stock, representing 0% of the class; its reported sole and shared voting and dispositive powers were each 0.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





34962G208

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Glazer Capital, LLC
Signature:Paul J. Glazer
Name/Title:Paul J. Glazer, Managing Member
Date:11/16/2026
Paul J. Glazer
Signature:Paul J. Glazer
Name/Title:Paul J. Glazer
Date:11/16/2026

Keep reading